I 

115TH CONGRESS 

1ST SESSION H. R. 1310 

To support programs for mosquito-borne and other vector-borne disease 

surveillance and control. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 2, 2017 

Mr. SOTO (for himself, Mr. CURBELO of Florida, Ms. CASTOR of Florida, Mr. 

GAETZ, Mr. CRIST, Mrs. DEMINGS, Mr. DEUTCH, Ms. FRANKEL of Florida, Mr. HASTINGS, Mr. LAWSON of Florida, Mrs. MURPHY of Florida, 

Mr. PERLMUTTER, Ms. WASSERMAN SCHULTZ, and Ms. WILSON of Florida) introduced the following bill; which was referred to the Committee 

on Energy and Commerce 

A BILL 

To support programs for mosquito-borne and other vectorborne disease surveillance and control. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Strengthening Mos5 quito Abatement for Safety and Health Act’’ or the 

6 ‘‘SMASH Act’’. 


SSpencer on DSK4SPTVN1PROD with BILLS
2 

•HR 1310 IH

1 SEC. 2. REAUTHORIZATION OF MOSQUITO ABATEMENT FOR 

2 SAFETY AND HEALTH PROGRAM. 

3 Section 317S of the Public Health Service Act (42 

4 U.S.C. 247b–21) is amended— 

5 (1) in subsection (a)(1)(B)— 

6 (A) by inserting ‘‘including programs to 

7 address emerging infectious mosquito-borne dis8 eases,’’ after ‘‘control programs,’’; and 

9 (B) by inserting ‘‘or improving existing 

10 control programs’’ before the period at the end; 

11 (2) in subsection (b)— 

12 (A) in paragraph (1), by inserting ‘‘, in13 cluding improvement,’’ after ‘‘operation’’; 

14 (B) in paragraph (2)— 

15 (i) in subparagraph (A)— 

16 (I) in clause (ii), by striking ‘‘or’’ 

17 at the end; 

18 (II) in clause (iii), by striking the 

19 semicolon at the end and inserting ‘‘, 

20 including an emerging infectious mos21 quito-borne disease that presents a se22 rious public health threat; or’’; and 

23 (III) by adding at the end the 

24 following: 

25 ‘‘(iv) a public health emergency due to 

26 the incidence or prevalence of a mosquitoVerDate Sep 11 2014 01:06 Mar 08, 2017 Jkt 069200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H1310.IH H1310

SSpencer on DSK4SPTVN1PROD with BILLS
3 

•HR 1310 IH

1 borne disease that presents a serious pub2 lic health threat.’’; and 

3 (ii) in subparagraph (D), by inserting 

4 ‘‘or that demonstrates to the Secretary 

5 that the control program is consistent with 

6 existing State mosquito control plans, or 

7 policies, or other applicable State pre8 paredness plans’’ before the period at the 

9 end; 

10 (C) in paragraph (4)(C), by striking ‘‘that 

11 extraordinary’’ and all that follows through the 

12 period at the end and inserting ‘‘that— 

13 ‘‘(i) extraordinary economic conditions 

14 in the political subdivision or consortium of 

15 political subdivisions involved justify the 

16 waiver; or 

17 ‘‘(ii) the geographical area covered by 

18 a political subdivision or consortium for a 

19 grant under paragraph (1) has an extreme 

20 need due to— 

21 ‘‘(I) the size or density of the 

22 human population; 

23 ‘‘(II) the size or density of the 

24 mosquito population; or 


SSpencer on DSK4SPTVN1PROD with BILLS
4 

•HR 1310 IH

1 ‘‘(III) the severity of the mos2 quito-borne disease, such that ex3 pected serious adverse health out4 comes for the human population jus5 tify the waiver.’’; and 

6 (D) by amending paragraph (6) to read as 

7 follows: 

8 ‘‘(6) NUMBER OF GRANTS.—A political subdivi9 sion or a consortium of political subdivisions may 

10 not receive more than one grant under paragraph 

11 (1).’’; and 

12 (3) in subsection (f)— 

13 (A) in paragraph (1), by striking 

14 ‘‘$100,000,000 for fiscal year 2003, and such 

15 sums as may be necessary for each of fiscal 

16 years 2004 through 2007’’ and inserting 

17 ‘‘$130,000,000 for each of fiscal years 2018 

18 through 2023’’; 

19 (B) in paragraph (2), by striking ‘‘the 

20 Public Health Security and Bioterrorism Pre21 paredness and Response Act of 2002’’ and in22 serting ‘‘other medical and public health pre23 paredness and response laws’’; and 

24 (C) in paragraph (3)— 


SSpencer on DSK4SPTVN1PROD with BILLS
5 

•HR 1310 IH

1 (i) in the heading, by striking ‘‘2004’’ 

2 and inserting ‘‘2018’’; and 

3 (ii) by striking ‘‘2004’’ and inserting 

4 ‘‘2018’’. 

5 SEC. 3. EPIDEMIOLOGY-LABORATORY CAPACITY GRANTS. 

6 Section 2821 of the Public Health Service Act (42 

7 U.S.C. 300hh–31) is amended— 

8 (1) in subsection (a)(1), by inserting ‘‘, includ9 ing mosquito and other vector-borne diseases,’’ after 

10 ‘‘infectious diseases’’; and 

11 (2) in subsection (b), by striking ‘‘2010 through 

12 2013’’ and inserting ‘‘2018 through 2023’’. 

13 SEC. 4. GAO STUDY. 

14 (a) STUDY.—The Comptroller General of the United 

15 States shall conduct a study on the state of surveillance 

16 and control of mosquito-borne infectious diseases in the 

17 United States and territories, including the state of pre18 paredness for conducting such surveillance and control. 

19 The study shall include— 

20 (1) a description of the infrastructure and pro21 grams for mosquito control in the United States, in22 cluding— 

23 (A) how such infrastructure and programs 

24 are organized and implemented at the Federal, 

25 State, and local levels, including with respect to 


SSpencer on DSK4SPTVN1PROD with BILLS
6 

•HR 1310 IH

1 departments and agencies of the States, and 

2 local organizations (including special districts) 

3 involved in such control programs; 

4 (B) the role of the private sector in such 

5 activities; 

6 (C) how the authority for mosquito control 

7 impacts such activities; and 

8 (D) the resources for such infrastructure 

9 and programs, including Federal, State, and 

10 local funding sources; 

11 (2) how mosquito and other vector-borne dis12 ease surveillance and control is integrated into Fed13 eral, State, and local preparedness plans and ac14 tions, including how zoonotic surveillance is inte15 grated into infectious disease surveillance to support 

16 real-time situational surveillance and awareness; 

17 (3) Federal, State, and local laboratory capacity 

18 for emerging vector-borne diseases, including mos19 quito-borne and other zoonotic diseases; and 

20 (4) any regulatory challenges for developing and 

21 utilizing vector-control technologies and platforms as 

22 part of mosquito control strategies. 

23 (b) CONSULTATIONS.—In conducting the study under 

24 subsection (a), the Comptroller General of the United 

25 States shall consult with— 


SSpencer on DSK4SPTVN1PROD with BILLS
7 

•HR 1310 IH

1 (1) State and local public health officials in2 volved in mosquito and other vector-borne disease 

3 surveillance and control efforts; 

4 (2) researchers and manufacturers of mosquito 

5 control products; 

6 (3) stakeholders involved in mosquito abate7 ment activities; 

8 (4) infectious disease experts; and 

9 (5) entomologists involved in mosquito-borne 

10 disease surveillance and control efforts. 

11 (c) REPORT.—Not later than 18 months after the 

12 date of enactment of this Act, the Comptroller General 

13 of the United States shall submit to the Committee on 

14 Health, Education, Labor, and Pensions of the Senate and 

15 the Committee on Energy and Commerce of the House 

16 of Representatives a report containing the results of the 

17 study conducted under subsection (a) and relevant rec18 ommendations for Zika virus and other mosquito-borne 

19 diseases preparedness and response efforts. 

Æ 


SSpencer on DSK4SPTVN1PROD with BILLS